Prognostic impact of RAS mutations in patients with myelodysplastic syndrome.
about
Detectable FLT3-ITD or RAS mutation at the time of transformation from MDS to AML predicts for very poor outcomesMEK1 is required for the development of NRAS-driven leukemia.I walk the line: how to tell MDS from other bone marrow failure conditions.The molecular pathogenesis of the myelodysplastic syndromes.RAS Promotes Proliferation and Resistances to Apoptosis in Meningioma.Genetics and Epigenetics of Myelodysplastic Syndromes and Response to Drug Therapy: New Insights.Genetic stratification in myeloid diseases: from risk assessment to clinical decision support tool.Screening of mutations in the additional sex combs like 1, transcriptional regulator, tumor protein p53, and KRAS proto-oncogene, GTPase/NRAS proto-oncogene, GTPase genes of patients with myelodysplastic syndrome.Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.Dynamic acquisition of FLT3 or RAS alterations drive a subset of patients with lower risk MDS to secondary AML.
P2860
Q36770211-4A470792-F511-424A-8B22-E4D9787EB9D2Q37696978-65A03D78-EB96-4587-B9C0-13D768ABF148Q38235622-462B5B1B-9DC3-4B9E-BE22-15C58E5AB503Q38341998-6806DD10-85E6-4BF0-9EBE-FA4975FF2336Q38782798-A0431D54-FD05-410E-BDBA-E607B169D787Q39069357-4537F2D5-7857-450E-828F-C64F074AB6BCQ39100115-8154B763-4D9B-4BAB-A7E7-EF8EEBD7F86FQ41530601-44E9C621-1989-48EB-A6D0-7255A60EBAD1Q42660774-BD048DDC-4598-4299-8EB5-15DB00C65F54Q50900611-7366389D-C5BB-4CC2-8A83-5C8B8EA38A24
P2860
Prognostic impact of RAS mutations in patients with myelodysplastic syndrome.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Prognostic impact of RAS mutations in patients with myelodysplastic syndrome.
@ast
Prognostic impact of RAS mutations in patients with myelodysplastic syndrome.
@en
type
label
Prognostic impact of RAS mutations in patients with myelodysplastic syndrome.
@ast
Prognostic impact of RAS mutations in patients with myelodysplastic syndrome.
@en
prefLabel
Prognostic impact of RAS mutations in patients with myelodysplastic syndrome.
@ast
Prognostic impact of RAS mutations in patients with myelodysplastic syndrome.
@en
P2093
P2860
P50
P356
P1476
Prognostic impact of RAS mutations in patients with myelodysplastic syndrome.
@en
P2093
Alfonso Quintás-Cardama
Aref Al-Kali
Carlos Bueso-Ramos
Jorges Cortes
Raja Luthra
P2860
P304
P356
10.1002/AJH.23410
P50
P577
2013-03-20T00:00:00Z